Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin Drug Eluting Beads (DEB) for unresectable Hepatocelluar Carcinoma (HCC)

Journal of Surgical Oncology

Volumn 101, Issue 6, 2010, Pages 476-480

  Dhanasekaran, Renumathy ^a   Kooby, David A ^a   Staley, Charles A ^a   Kauh, John S ^a   Khanna, Vinit ^a   Kim, Hyun S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Doxorubicin drug eluting beads (DEB); Hepatocellular carcinoma (HCC); Survival; TACE; Transcatheter therapy

Indexed keywords

CISPLATIN; DOXORUBICIN; ETHIODIZED OIL; MITOMYCIN C;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHOLECYSTITIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELUTING BEAD; DRUG SAFETY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RATING SCALE; SURVIVAL TIME;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77950810261     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21522     Document Type: Article

References (19)

1. El-Serag HB, Rudolph KL: Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 2007;132: 2557-2576. (Pubitemid 46890874)
2. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. El-Serag HB: Hepatocellular carcinoma. Recent Trends US Gastroenterol 2004;127:S27-S34.
4. Kassahun WT, Fangmann J, Harms J, et al.: Liver resection and transplantation in the management of hepatocellular carcinoma: A review. Exp Clin Transplant 2006;4:549-558. (Pubitemid 46443886)
5. Guan YS, Liu Y: Interventional treatments for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2006;5:495-500.
6. Lubienski A, Simon M, Lubienski K, et al.: Update on chemoinfusion and chemoembolization treatments. Radiologe 2007; 47:1097-1106, 1108.
7. Llovet JM, Real MI, Montana X, et al.: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 2002;359:1734-1739. (Pubitemid 34607087)
8. Lo CM, Ngan H, Tso WK, et al.: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-1171. (Pubitemid 34454013)
9. Ramsey DE, Kernagis LY, Soulen MC, et al.: Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002;13:S211-S221.
10. Malagari K: Drug-eluting particles in the treatment of HCC: Chemoembolization with doxorubicin-loaded DC beads. Expert Rev Anticancer Ther 2008;8:1643-1650.
11. Kalva SP, Thabet A, Wicky S, et al.: Advances in transarterial therapy of primary and secondary liver malignancies. Radiographics 2008;28:101-117.
12. Lewis AL, Taylor RR, Hall B, et al.: Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 2006;17:1335-1343. (Pubitemid 44259017)
13. Hong K, Khwaja A, Liapi E, et al.: New intra-arterial drug delivery system for the treatment of liver cancer: Preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 2006;12:2563-2567.
14. Varela M, Real MI, Burrel M, et al.: Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics. J Hepatol 2007;46:474-481. (Pubitemid 46201723)
15. Lammer J, Malagari K, Vogl T, et al.: Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION V Study. Cardiovasc Intervent Radiol 2009 [Epub ahead of print].
16. Murray KF, Carithers RL, Jr.: AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology 2005;41:1407-1432.
17. Trotti A, Colevas AD, Setser A, et al.: CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-181. (Pubitemid 36962641)
18. Lewis AL, Gonzalez MV, Lloyd AW, et al.: DC bead: In vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 2006;17:335-342.
19. Malagari K, Chatzimichael K, Alexopoulou E, et al.: Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: Results of an open-label study of 62 patients. Cardiovasc Intervent Radiol 2008;31:269-280.